Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-06 Sale |
2023-02-07 4:30 pm |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
20,340 | $1.75 | $35,595 | 2,280,713 (Direct) |
View |
| 2023-02-02 Sale |
2023-02-06 5:41 pm |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
5,388 | $1.6602 | $8,945 | 144,612 (Direct) |
View |
| 2023-02-02 Sale |
2023-02-06 5:40 pm |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
5,389 | $1.6601 | $8,946 | 196,519 (Direct) |
View |
| 2023-02-02 Sale |
2023-02-06 5:40 pm |
RIGEL PHARMACEUTICALS INC | RIGL | Dummer Wolfgang EVP & CMO |
5,389 | $1.6601 | $8,946 | 72,459 (Direct) |
View |
| 2022-06-09 Purchase |
2022-06-13 4:36 pm |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
1,000,000 | $0.6884 | $688,400 | 1,391,776 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-01-23 Option Award |
2024-01-25 9:16 pm |
N/A 2034-01-23 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
366,000 | $0 | 572,519 (Direct) |
View |
| 2023-05-26 Option Award |
2023-07-12 6:45 pm |
N/A 2033-05-26 |
RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director |
55,000 | $0 | 105,000 (Direct) |
View |
| 2023-05-26 Option Award |
2023-07-12 6:45 pm |
N/A 2033-05-26 |
RIGEL PHARMACEUTICALS INC | RIGL | MOOS WALTER H Director |
55,000 | $0 | 107,222 (Direct) |
View |
| 2023-05-26 Option Award |
2023-07-12 6:45 pm |
N/A 2033-05-26 |
RIGEL PHARMACEUTICALS INC | RIGL | Wasman Jane Director |
55,000 | $0 | 105,000 (Direct) |
View |
| 2023-05-26 Option Award |
2023-07-12 6:45 pm |
N/A 2033-05-26 |
RIGEL PHARMACEUTICALS INC | RIGL | LYONS GARY A Director |
55,000 | $0 | 105,000 (Direct) |
View |
| 2023-05-26 Option Award |
2023-07-12 6:45 pm |
N/A 2033-05-26 |
RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director |
55,000 | $0 | 73,750 (Direct) |
View |
| 2023-05-26 Option Award |
2023-07-12 6:45 pm |
N/A 2033-05-26 |
RIGEL PHARMACEUTICALS INC | RIGL | Kotzin Brian L. Director |
55,000 | $0 | 105,000 (Direct) |
View |
| 2023-05-26 Option Award |
2023-07-12 6:45 pm |
N/A 2033-05-26 |
RIGEL PHARMACEUTICALS INC | RIGL | HANNAH ALISON L. Director |
55,000 | $0 | 86,250 (Direct) |
View |
| 2023-01-26 Option Award |
2023-02-07 4:30 pm |
N/A 2033-01-26 |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
900,000 | $0 | 2,280,713 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 9:45 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | Dummer Wolfgang EVP & CMO |
50,000 | $0 | 100,000 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 9:45 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
200,000 | $0 | 400,000 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 9:45 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
238,000 | $0 | 426,908 (Direct) |
View |
| 2023-01-26 Option Award |
2023-01-30 9:45 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
290,000 | $0 | 410,000 (Direct) |
View |
| 2022-12-28 Option Award |
2022-12-30 4:30 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-12-28 Option Award |
2022-12-30 4:30 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
200,000 | $0 | 200,000 (Direct) |
View |
| 2022-12-28 Option Award |
2022-12-30 4:30 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | Dummer Wolfgang EVP & CMO |
50,000 | $0 | 50,000 (Direct) |
View |
| 2022-12-28 Option Award |
2022-12-30 4:30 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
50,000 | $0 | 50,000 (Direct) |
View |
Ownership |
2022-12-16 4:32 pm |
N/A 2032-12-08 |
RIGEL PHARMACEUTICALS INC | RIGL | Furey Raymond J. EVP, GC & Corp Sec |
0 | $0 | 187,500 (Direct) |
View |
| 2022-09-14 Option Award |
2022-09-16 4:15 pm |
N/A 2029-01-23 |
RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. |
81,250 | $0 | 81,250 (Direct) |
View |
| 2022-09-14 Option Award |
2022-09-16 4:15 pm |
N/A 2029-01-23 |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
300,000 | $0 | 300,000 (Direct) |
View |
| 2022-09-14 Option Award |
2022-09-16 4:15 pm |
N/A 2029-01-23 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
81,250 | $0 | 81,250 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-23 5:50 pm |
N/A 2032-05-20 |
RIGEL PHARMACEUTICALS INC | RIGL | MOOS WALTER H Director |
55,000 | $0 | 82,222 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-23 5:50 pm |
N/A 2032-05-20 |
RIGEL PHARMACEUTICALS INC | RIGL | Wasman Jane Director |
55,000 | $0 | 80,000 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-23 5:50 pm |
N/A 2032-05-20 |
RIGEL PHARMACEUTICALS INC | RIGL | LAPOINTE ANTHONY GREGG Director |
55,000 | $0 | 80,000 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-23 5:50 pm |
N/A 2032-05-20 |
RIGEL PHARMACEUTICALS INC | RIGL | LYONS GARY A Director |
55,000 | $0 | 80,000 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-23 5:50 pm |
N/A 2032-05-20 |
RIGEL PHARMACEUTICALS INC | RIGL | HANNAH ALISON L. Director |
55,000 | $0 | 61,250 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-23 5:50 pm |
N/A 2032-05-20 |
RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director |
41,250 | $0 | 41,250 (Direct) |
View |
| 2022-05-20 Option Award |
2022-05-23 5:50 pm |
N/A 2032-05-20 |
RIGEL PHARMACEUTICALS INC | RIGL | Kotzin Brian L. Director |
55,000 | $0 | 80,000 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 8:47 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP &Chief Financial Officer |
150,000 | $0 | 228,908 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 8:46 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | Dummer Wolfgang EVP & CMO |
150,000 | $0 | 167,848 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 8:45 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | Santos David A EVP, Chief Commercial Officer |
150,000 | $0 | 160,000 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 8:43 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | RODRIGUEZ RAUL R CEO, President |
600,000 | $0 | 791,776 (Direct) |
View |
| 2022-01-24 Option Award |
2022-01-26 8:42 pm |
N/A 2032-01-24 |
RIGEL PHARMACEUTICALS INC | RIGL | VANCE DOLLY EVP Corp. Affairs, G.C., Sect. |
150,000 | $0 | 160,260 (Direct) |
View |
| 2021-12-16 Option Award |
2021-12-17 4:22 pm |
N/A 2031-12-16 |
RIGEL PHARMACEUTICALS INC | RIGL | Ali-Jackson Kamil Director |
120,000 | $0 | 120,000 (Direct) |
View |
| 2021-11-04 Option Award |
2021-11-05 7:06 pm |
N/A 2029-01-23 |
RIGEL PHARMACEUTICALS INC | RIGL | Schorno Dean L EVP & Chief Financial Officer |
81,250 | $0 | 81,250 (Direct) |
View |